Innovative Data Platform uMed's ACCESS Research Platform provides a comprehensive and decentralized approach to gathering real-world evidence, making it a valuable tool for pharmaceutical and biotech companies seeking faster, patient-centric data collection solutions.

Global Healthcare Network With its embedded platform across international healthcare institutions, uMed offers opportunities for collaborative research initiatives and expansion into new markets focused on real-world evidence generation.

Growth Potential Operating within the research services industry with revenues between 1M and 10M, uMed shows potential for growth, especially when targeting mid-sized and large life sciences organizations looking for innovative evidence solutions.

Technology Integration Utilizing a tech stack that includes cloud services and engagement tools, uMed can appeal to clients interested in leveraging scalable, secure, and integrated digital research platforms.

Competitive Positioning Compared to peers like Deep 6 AI and BenevolentAI, uMed's focus on patient-generated data combined with RWE provides a unique selling point, opening sales opportunities with organizations investing in decentralized and real-world data approaches.